Skip to content
Home
About Us
Resources
Profiles Metrics
Authors Directory
Institutions Directory
Top Authors
Top Institutions
Top Sponsors
AI Digest
Contact Us
Menu
Home
About Us
Resources
Profiles Metrics
Authors Directory
Institutions Directory
Top Authors
Top Institutions
Top Sponsors
AI Digest
Contact Us
Home
About Us
Resources
Profiles Metrics
Authors Directory
Institutions Directory
Top Authors
Top Institutions
Top Sponsors
AI Digest
Contact Us
Menu
Home
About Us
Resources
Profiles Metrics
Authors Directory
Institutions Directory
Top Authors
Top Institutions
Top Sponsors
AI Digest
Contact Us
Publication Details
AFRICAN RESEARCH NEXUS
SHINING A SPOTLIGHT ON AFRICAN RESEARCH
medicine
Effect of aspirin on short-term outcomes in hospitalized patients with COVID-19
Vascular Medicine (United Kingdom), Volume 26, No. 6, Year 2021
Notification
URL copied to clipboard!
Description
Coronavirus disease 2019 (COVID-19) caused by SARS-CoV-2 is an ongoing viral pandemic marked by increased risk of thrombotic events. However, the role of platelets in the elevated observed thrombotic risk in COVID-19 and utility of antiplatelet agents in attenuating thrombosis is unknown. We aimed to determine if the antiplatelet effect of aspirin may mitigate risk of myocardial infarction, cerebrovascular accident, and venous thromboembolism in COVID-19. We evaluated 22,072 symptomatic patients tested for COVID-19. Propensity-matched analyses were performed to determine if treatment with aspirin or nonsteroidal anti-inflammatory drugs (NSAIDs) affected thrombotic outcomes in COVID-19. Neither aspirin nor NSAIDs affected mortality in COVID-19. Thus, aspirin does not appear to prevent thrombosis and death in COVID-19. The mechanisms of thrombosis in COVID-19, therefore, appear distinct and the role of platelets as direct mediators of SARS-CoV-2-mediated thrombosis warrants further investigation. © The Author(s) 2021.
Authors & Co-Authors
Hariri, Essa H.
United States, Cleveland
Cleveland Clinic Foundation
Kalra, Ankur
United States, Cleveland
Cleveland Clinic Foundation
McCrae, Keith R.
United States, Cleveland
Cleveland Clinic Foundation
Elbadawi, Ayman
United States, Galveston
The University of Texas Medical Branch at Galveston
Kapadia, Samir R.
United States, Cleveland
Cleveland Clinic Foundation
Cameron, Scott J.
United States, Cleveland
Cleveland Clinic Foundation
Statistics
Citations: 21
Authors: 6
Affiliations: 2
Identifiers
Doi:
10.1177/1358863X211012754
ISSN:
1358863X
Research Areas
Covid